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Abstract.  Cellubrevin is a member of the synap- 
tobrevin/VAMP family of SNAREs, which has a broad 
tissue distribution.  In fibroblastic cells it is concen- 
trated in the vesicles which recycle transferrin  recep- 
tors but its role in membrane trafficking and fusion re- 
mains to be demonstrated.  Cellubrevin, like the 
synaptic vesicle proteins synaptobrevins I and 1I, can 
be cleaved by tetanus toxin, a metallo-endoprotease 
which blocks neurotransmitter  release. However, non- 
neuronal cells are unaffected by the toxin due to lack 
of cell surface receptors for its heavy chain.  To deter- 
mine whether cellubrevin cleavage impairs exocytosis 
of recycling vesicles, we tested the effect of tetanus 
toxin light chain on the release of preinternalized 
transferrin  from streptolysin-O-perforated CHO cells. 
The release was found to be temperature and ATP de- 
pendent as well as NEM sensitive. Addition of tetanus 
toxin light chain,  but not of a proteolytically inactive 
form of the toxin, resulted in a partial inhibition of 
transferrin  release which correlated with the toxin- 
mediated cleavage of cellubrevin.  The residual release 
of transferrin  occurring after complete ceUubrevin 
degradation was still ATP dependent.  Our results indi- 
cate that cellubrevin plays an important role in the 
constitutive exocytosis of vesicles which recycle plas- 
malemma receptors.  The incomplete inhibition of 
transferrin  release produced by the toxin suggests the 
existence of a cellubrevin-independent exocytotic 
mechanism,  which may involve tetanus toxin- 
insensitive proteins of the synaptobrevin/VAMP family. 
S 
YNAPTIC vesicles are highly  specialized  secretory or- 
ganelles  which undergo regulated  exocytosis at syn- 
apses. They store and secrete nonpeptide neurotrans- 
mitters and are continuously regenerated in nerve endings by 
cycles of exo-endocytosis (Ceccarelli et al., 1973;  Heuser 
and  Reese,  1973).  They differ  in  many biochemical and 
functional properties from the secretory granules of the clas- 
sicai regulated secretory pathway which are assembled and 
loaded with content in the region of the trans-Golgi  network 
(De CamiUi and Jahn,  1990).  Instead,  they appear to be 
closely related  to the vesicular carriers which functionally 
connect early endosomes to the plasmalemma since many 
similarities  between the recycling pathways of plasmalemma 
receptors (for example the transferrin  [Tf] 1 receptor) and 
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the  recycling  of synaptic  vesicles  have  become apparent 
(Cameron et al., 1991; Linstedt and Kelly, 1991; McPherson 
and De Camilli,  1994).  One important difference between 
the  properties  of synaptic  vesicles  and  those of vesicles 
which carry recycling  receptors to the cell surface,  is the 
regulation  of the exocytotic event.  In the case of synaptic 
vesicles (Del Castillo and Katz,  1954), but not in the case 
of "If receptor-containing  vesicles (Mellman et al.,  1987), 
exocytosis is highly regulated in a phasic fashion by cytosolic 
Ca  2+. However, even in the case of synaptic vesicles,  a low 
rate of constitutive exocytosis can be observed in the absence 
of stimuli,  suggesting that Ca  2+ is involved in some regula- 
tory control of the fusion event, rather being an integral par- 
ticipant in the fusion reaction (Del CastiUo and Katz,  1954; 
Katz and Miledi, 1968; Matteoli et ai., 1992). In agreement 
with  these considerations,  a  convergence  of biochemical 
work carried out primarily in neurons and of genetic studies 
in  yeast,  have  suggested  that  the same basic fusion ma- 
chinery may be used both for regulated and constitutive exo- 
cytosis in all cells (Aalto et al., 1992; Bennett and ScheUer, 
1993; S611ner et al.,  1993b;  Sudhof et al.,  1993). 
Putative key components of the fusion complex are small 
polypeptides anchored either to the vesicle (v-SNAREs) or 
to  the  plasmalemma  (t-SNAREs)  and  cytosolic  factors 
which are recruited to the site of fusion. In the case of synap- 
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(or  vesicle-associated  membrane  proteins  [VAMPs])  and 
their plasmalemma counterparts are syntaxin and the synap- 
tosome-associated protein of 25 kD (SNAP-25) (S6Uner et 
al., 1993a,b). Synaptobrevin was found to interact with syn- 
taxin and SNAP-25, and this complex in turn interacts in an 
ATP-dependent  fashion  with NSF and c~/~/and  3, soluble 
NSF attachment protein (SNAP) (S61iner  et al.,  1993a,b). 
The hypothesis that synaptobrevin, syntaxin, and SNAP- 
25 are key membrane components of the exocytotic complex 
for synaptic vesicles is strongly supported by the finding that 
each of these three proteins is the target for the proteolytic 
action of clostridial neurotoxins (Link et al.,  1992; Schiavo 
et al.,  1992a,b, 1993a,b; Blasi et al.,  1993a,b; Binz et al., 
1994; Yamasaki et al.,  1994a,b), which act as potent inhibi- 
tors of synaptic vesicle exocytosis (Niemann,  1991;  Mon- 
tecucco and  Schiavo,  1993).  Since homologues of synap- 
tobrevin (Protopopov et al.,  1993),  syntaxin (Aalto et al., 
1993),  SNAP-25  (V.  Bankaitis,  personal communication), 
N-ethylmaleimide-sensitive fusion protein (NSF) (Wilson et 
al.,  1989), and od/~- and 3,-SNAPs (Clary et al.,  1990; Griff 
et al.,  1992) are known to be involved in exocytosis from 
yeast, members of these protein families must participate in 
exocytosis from  all  cells.  Accordingly,  NSF  and  SNAPs 
(Whiteheart  et al.,  1993) are ubiquituously expressed and 
isoforms of synaptobrevin and syntaxins have been recently 
identified outside the nervous system (Cain et al., 1992; Ben- 
nett et al., 1993; Chin et al., 1993; McMahon et al., 1993). 
Cellubrevin, which shares a very high degree of homology 
with synaptobrevin I and II (Trimble et al.,  1988; Baumert 
et al.,  1989; Elferink et al.,  1989) is expressed in all non- 
neuronal tissues examined (McMahon et al., 1993). Proteins 
of the synaptobrevin/VAMP family are also expressed in all 
tissues of Drosophila (Chin et al.,  1993; DiAntonio et al., 
1993).  In  fibroblastic  cells,  ceUubrevin is  present  on  Tf 
receptor-containing  vesicles (McMahon et al.,  1993), em- 
phasizing the close similarity of Tf receptor-containing vesi- 
cles to synaptic vesicles (Cameron et al.,  1991).  The great 
homology between ceUubrevin and synaptobrevin at the site 
where  synaptobrevin  is  cleaved  by  tetanus  toxin  (TeTx) 
(McMahon et al.,  1993; Yamasaki et al.,  1994a) offers an 
opportunity to test the role of cellubrevin in vesicle recy- 
cling. Indeed, ceUubrevin was found to be cleaved by tetanus 
toxin in both cell extracts and living cells (Link et al., 1993; 
McMahon et al., 1993; Yamasaki et al., 1994a). Since non- 
neuronal cells do not have the receptor for the toxin at their 
surface, experiments on living cells were performed by in- 
troducing the proteolytically active portion of the toxin (the 
light  chain  [TeTx-LC])  via a  transient  eDNA transfection 
procedure (McMahon et al.,  1993). In these experiments, 
however, an effect of the toxin on exocytosis was not inves- 
tigated and a role of cellubrevin in vesicle exocytosis remains 
to be demonstrated. 
In the present study we have established an assay to moni- 
tor exocytosis of Tf-containing vesicles from streptolysin-O 
(SL-O)-perforated cells. We have then used this assay to de- 
termine whether cleavage of cellubrevin produced by TeTx- 
LC leads to an impairment of the constitutive exocytosis of 
these vesicles.  Our results demonstrate  that TeTx-LC pro- 
duces a reduction, although not a block, of exocytosis which 
correlates with cleavage of cellubrevin. They provide a first 
direct functional demonstration that a protein of the synap- 
tobrevin family is involved in the constitutive exocytosis of 
recycling vesicles in nonneuronal cells, and suggest the exis- 
tence  of a  tetanus  toxin-insensitive  fusion  mechanism  in 
CHO ceils. 
Materials and Methods 
Materials 
[12~I]diferric Tf (90 tLCi/rni) and [125I]protein A  (126 pCi/ml) were pur- 
chased from NEN (Wdmington, DE), brefeldin A from Epicentre Technol- 
ogies (Madison, WI), reduced  SL-O from Murex Diagnostics  (Norcross, 
GA), fluorescein-labeled  phalloidin from Molecular Probes, Inc. (Eugene, 
OR), ATP (magnesium salt) and hexokinase from SIGMA (St. Louis, MO), 
and human diferric Tf from GIBCO BRL (Gaithersburg,  MD). Tissue cul- 
ture reagents were from GIBCO BRL. Stock solutions of the recombinant 
light chain of TeTx-LC and of the proteolytically  inactive mutant ([Q234]- 
TeTx-LC) were prepared as described (McMahon et al.,  1993) and were 
13 t~M in buffer T (10 mM PIPES,  150 mM K-glutamate,  pH 7.2). 
Antibodies 
Antibodies specific for cellubrevin (MC16) and for synaptobrevin  I (MC9), 
respectively, were generated in rabbits by injecting synthetic peptides corre- 
sponding to the NH2-terminal amino acids of the two proteins followed by 
a  cysteine  (sequences:  MSTGVPSGSSAATGC  and  MSAPAQPPAEG- 
TEGAC,  respectively).  For immunocytochemistry,  the MC16 serum was 
affinity purified using the cellubrevin peptide coupled to EAH ~-pbarose 
4B (Pharmacia, Uppsala, Sweden). The following antibodies were obtained 
through generous gifts:  anti-human "If receptor  monoclonal antibodies 
(H68.4)  (Dr.  I. Trowbridge,  Salk Institute, La Jolla, CA); anti-SCAMPs 
monoclonal antibodies (SG7C12) (Dr.  D.  Castle,  University of Virginia 
School of Medicine,  Charlottesville,  VA); anfi-synaptobrevin  I1 serum and 
monoclonal antibody (Cli0.1) which recognizes all synaptobrevin isoforms 
(Dr. R. Jalm, Yale University School of Medicine, New Haven, CT); poly- 
clonal serum (anti-VAMP2/trpE)  raised against the core region of synap- 
tobrevin II (residues  32 to 97) (Trimhle et aI., 1988) which is highly con- 
served (McMahon et al.,  1993)  in synaptobrevin/VAMP  isoforms  from 
invertebrates to mammals (Dr. R. Scheller, Stanford University, Stanford, 
CA). Monoclonal antibodies directed against ~- and/~-tubulins and human 
Tf were purchased from Amersham Corp.  (Arlington Heights, IL) and Ac- 
curate Chemical and Science Corp. (Weslbury, NY), respectively. 
Cell Culture 
CHO cells were grown as monolayer cultures in Dulbecco's modified Eagle's 
media supplemented with 10% (vol/vol) fetal calf serum, 34 t~g/ml proline, 
100 U/ml penicillin, and 100 ttg/mi streptomycin  at 37°C in a humidified 
atmosphere containing 5%  CO2.  Semiconfluent  monolayers  containing 
4.5-6.0  ×  104 cells/cm  2 were used for all experiments. 
Immunocytochemistry 
CHO cells were grown for 48 h on poly-[L]ornithine-coated  glass coverslips 
and fixed with 4%  formaldehyde  in phosphate buffer containing 4% su- 
crose.  Immunofluorescence  was performed as described (Cameron et aL, 
1991). In some cases cells were allowed to internalize "If (human diferric 
Tf, 20/~g/ml final concentration) for 1 h at 37°C in culture medium, briefly 
rinsed in the same buffer, and then fixed. Internalized "If was then stained 
with secondary antibodies as described (Cameron et al.,  1991). Brefeldin 
A (10 ~g/ml final concentration) was added during the last 15 rnin of the 
1-h "If internalization period in some experiments (Mundigl et ai.,  1993). 
SL-O perforation of the cells was performed as described by Miller and 
Moore (1991, 1992) (see also below).  Cells were then incubated at 37°C 
for 65 rain in the presence of 2 mM ATP (with and without TeTx-LC) and, 
subsequently,  fixed. 
Tf release  from SL-O-perforated Cells 
CHO  cells  were perforated  with  SL-O essentially  as described  by Miller 
and  Moore 0991, 1992).  Approximately 24 × 106  cells  were  resuspended 
in phosphate-buffered  saline containing 5 mM EDTA, pelleted at 350 g for 
5 rain at 4°C, re,suspended in 10 ml of buffer K (20 raM Hepes, 128 mM 
NaCI, 3 mM KCI, 1 mM Na2HPO4, 1.2 mM MgSO4, 2.7 mM CaCI2, and 
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then resuspended in buffer K at a concentration of 5  x  104 cells//d and in- 
cubated in the presence of [125I]Tf (10 ~g/ml) for 1 h at 37"C (Podbilewicz 
and Mellman, 1990; Lippincott-Schwartz et al., 1991). The cell suspension 
was washed with 1 ml of ice-cold buffer K by sedimentation and resuspen- 
sion using an Eppendorf  5154C microcentrifuge. An aliquot of this material 
was used to study [125I]Tf release from intact cells. The remaining cell sus- 
pension was washed two times with  1 ml of ice-cold buffer A  (20 mM 
Hepes, 110 raM NaC1,  5.4 m_M KC1, 0.9 mM Na2HPO4,  10 mM MgC12, 
2 mM CaC12, and 11 mM glucose, pH 7.4,  with NaOH), resuspended in 
buffer A at the final concentration of 104 cells//~l,  and then mixed with an 
equal volume of buffer A containing SL-O (0.2 U/ml final concentration). 
After incubation on ice for 10 rain, excess SL-O was removed by centrifuga- 
tion and one wash with 1 mi of buffer B (20 mM Hepes, 100 mM K-glu- 
tamate, 40 mM KCI, and 5 mM EGTA, pH 7.2, with KOH) containing 2 
mM Mg-ATP and 5 mM free Mg  2+ (added as MgCI2).  The concentration 
of free Mg  2+  was calculated using the software by Foehr and Warehol 
(Ulm, Federal Republic of Germany). The pellet was then resuspended in 
buffer B.at a final density of 104 cells/~l and split into aliquots to which 
the concentrated toxins in buffer T, buffer T alone, or hexokinase and glu- 
cose for the ATP depletion experiments (final concentration of 30 U/ml and 
3 raM, respectively), were added (Miller and Moore, 1991,  1992).  100-td 
aliquots of treated and control cell suspensions were then incubated at 37°C 
for 5, 20, 35, or 65 min and the release of [t25I]Tf in the medium was deter- 
mined. As previously reported, the SL-O-induced formation of cell pores 
occurs as soon as the cells are shifted to 37°C (Ahnert-Hilger et al., 1989b). 
The 4"C control samples were obtained by returnin~ the cells to an ice bath 
after 5 rain at 37"C to allow pores to form. To study the effect of  N-ethylma- 
leimide (NEM), cells were first brought to 37"C for 2 min to allow SL-O- 
induced pore formation, then incubated on ice with 1 mM NEM for 15 rain 
and subsequently with 2 mM dithiothreitol (DTT) to quench NEM (Beckers 
et al., 1989;  Miller and Moore, 1991). Subsequently, cells were incubated 
at 37"C to assay release of [125I]Tf. Control incubations were performed by 
adding DTT together with NEM at the beginning of the incubation on ice 
(Beckers et al.,  1989). 
At each time point studied, triplicate samples were centrifuged and the 
supernatants and pellets were collected separately. The latter were resus- 
pended in 20/~1 of SDS gel sample buffer or 1% Triton X-100. The amounts 
of [t25I]Tf in the supernatants and corresponding pellets were measured in 
a 3' counter (LKB, Bromma, Sweden). In each experiment, an aliquot of 
the SL-O-treated cell suspension was pelleted at the beginning of the 37"C 
incubation (defined as 0 min). The amount of [125I]Tf recovered in the su- 
pernatant of this sample was defined as background and therefore sub- 
stracted from each individual release value obtained at later incubation 
times. The amount of [125I]Tf released was expressed as the percent of total 
amount of [125I]Tf present in each sample (supernatant plus pellet). Each 
experiment was repeated at least three times, and a single representative ex- 
periment is shown in each figure. Values are reported as the mean +  SD 
of three determinations. 
In pilot experiments, the effectiveness  of the permeabilization procedure 
for cells in suspension was assessed by incubating SL-O-treated cells with 
propidium iodide (1 #g/ml) or fluorescein-labeled phalloidin (50 nM) fol- 
lowed by flow cytometry analysis with a FACSTARplus cell sorter (Becton 
Dickinson, San Jose, CA) (excitation at 488 nm and emission at 630 nm 
and 530 nm, respectively). 
Western Blotting 
Proteins from pellets used for the release experiments described above were 
separated by SDS-PAGE (Schagger and yon Jagow,  1987) and analyzed by 
Western  blotting  for  cellubrevin,  secretory  carrier  membrane  protein 
(SCAMPs), ~  and ~-tubulin, and Tf receptor. Immunoreactive bands were 
visualized with [125I]protein A. 
Results 
Localization of Cellubrevin in CHO Cells 
As a premise to our studies we raised a rabbit anti-serum 
directed against the NH2-terminal region of rat cellubrevin 
which is divergent from the corresponding regions of synap- 
tobrevin I and II. The affinity-purified antibodies, which are 
highly specific for cellubrevin and do not recognize synap- 
tobrevin I and II, reacted very strongly with cellubrevin in 
formaldehyde-fixed CHO cells and allowed localization  of 
the  endogenous  protein  by  immunofluorescence.  Cellu- 
brevin  immunoreactivity  appeared  as  fine  puncta  sparse 
throughout  the  cytoplasm  (Fig.  1,  B,  D,  and  F).  These 
puncta were particularly  concentrated  in the region of the 
microtubule-organizing  center as demonstrated  by double 
immunofluorescence with anti-/~-tubulin antibodies (Fig.  1, 
C and D). This localization was very similar to the distribu- 
tion  of "If internalized  by  receptor-mediated  endocytosis 
during 1-h incubation (compare Fig. 1, A and B), a distribu- 
tion which is known to closely reflect the intracellular local- 
ization of'If receptors (Cameron et al.,  1991). More puncta 
appeared to be positive for cellubrevin than for internalized 
Tf; however, virtually all spots positive for Tf were also posi- 
tive for cellubrevin. After brefeldin A treatment (Lippincott- 
Schwartz  et al.,  1991)  tubules positive for internalized  Tf 
were also positive for cellubrevin (Fig.  1, A and B, insets), 
further emphasizing the colocalization of the two proteins. 
These  immunofluorescence  results  are  in  agreement  with 
those previously obtained by the staining of exogenous cel- 
lubrevin in cellubrevin-overexpressing CV1 cells (McMahon 
et al.,  1993). 
Release of  Preinternalized Tf  from SL-O-perforated 
CHO Cells 
The assay utilized in this study to monitor exocytosis of recy- 
cling vesicles is based on the well-characterized pH and iron 
dependency of the affinity of Tf for its receptor: the affinity 
of free "If (apo-Tf) is higher at acid pH, while the affinity of 
diferric Tf is higher at neutral pH (Maxfield and Yamashiro, 
1991; Dautry-Varsat et al.,  1983; Hopkins and Trowbridge, 
1983). Diferric Tf binds to receptors at the cell surface and 
is internalized by receptor-mediated endocytosis. At the acid 
pH of endosomes iron dissociates from Tf, while apo-Tf re- 
mains bound to the receptor and is incorporated  together 
with  the  receptor  in  endosome-derived  recycling  vesicles 
(McGraw  and  Maxfield,  1990;  Maxfield  and  Yamashiro, 
1991; Dautry-Varsat et al.,  1983; Hopkins and Trowbridge, 
1983). Following vesicle exocytosis, apo-Tf is released into 
the medium.  Thus,  the release of [~25I]Tf after a period of 
[~25I]Tf internalization  closely reflects exocytosis of consti- 
tutively recycling endosome-derived vesicles. This hypothe- 
sis has been validated in previous studies (Podbilewicz and 
Mellman,  1990;  Lippincott-Schwartz  et al.,  1991). 
We used the protocol of permeabilization  of CHO cells 
with  SL-O described by Miller  and Moore (1991,  1992). 
This procedure was found to allow the study of constitutive 
secretion via the biosynthetic pathway from CHO cells up to 
at least 90 min after perforation (Miller and Moore,  1991). 
Cells  grown  on coverslips were used for immunofluores- 
cence experiments, and cells in suspension for quantitative 
studies on the release of preinternalized [t25]Tf. To determine 
the  efficiency of the perforation  procedure  under  our  ex- 
perimental  conditions,  perforated  ceils were stained  with 
two membrane-impermeable compounds: fluorescein-labeled 
phalloidin,  which stains actin filaments, and propidium io- 
dide, which stains the nucleus. They were then analyzed by 
immunofluorescence  (cells  on  coverslips)  or  by  flow cy- 
tometry (cells in suspension). Virtually all cells were found 
to be perforated. The efficiency of the perforation procedure 
Galli et al.  Cellubrevin and Exocytosis of Recycling Vesicles  1017 Figure 1. Localization of endogenous cellubrevin in CHO cells. Double immunofluorescence micrographs. (A and B) Double labeling for 
cellubrevin (CB) and for human Tf (Tfuptake) after exposure of the cells to human Tf (20 #g/ml) for 1 h. The insets in the two fields 
show a detail of a cell which had been treated with brefeldin A (+BFA) during the last 15 min of Tf uptake. (C and D) Double labeling 
for fl-tubulin and for cellubrevin (CB). (E and F) Double labeling for actin (fluorescein-conjugated phalloidin) and for cellubrevin (CB). 
Bar, 14/~m (17/~m for the two insets). 
was further validated by the virtual complete cleavage of cel- 
lubrevin produced by TeTx-LC added to the incubation me- 
dium (see below). 
Light microscopy observation of perforated cells  incu- 
bated for 65 min in the presence of 2 mM ATP demonstrated 
a slight retraction of the cell edges. However, the intracellu- 
lar morphology was still strikingly preserved. As shown in 
Fig. 2, the microtubular and actin arrays were still present 
and  cellubrevin  immunoreactivity  was  not  substantially 
affected. The only noticeable difference from intact cells was 
a  partial  disassembly  of microtubules (compare Fig.  2  A 
[perforated cells] with Fig. 1 C [intact cells]) and a finer ap- 
pearance of cellubrevin immunoreactivity in the perforated 
cells (compare Fig. 2, B and D  [perforated cells] with Fig. 
1, B, D, and F  [intact cells]). The distribution of actin (Fig. 
2 C) was similar to that seen in control cells (Fig.  1 E). A 
well preserved intracellular organization was confirmed by 
electron microscopy, although the cytosolic matrix appeared 
to  have  been  partially  extracted  in  perforated  cells  (not 
shown). 
The  release  of preinternalized  [t25I]Tf  from perforated 
CHO cells in suspension cultures is shown in Fig. 3. Cells 
were  incubated  with  [125I]Tf for  1  h  at  37°C  and  then 
washed and incubated for 65 min with or without exposure 
to  SL-O  perforation.  In  65  min,  SL-O-treated cells  in- 
cubated with 2 mM ATP released about half of the amount 
of [125I]Tf  released by intact cells (Fig.  3). The kinetics of 
release were similar in intact and perforated cells but with 
values ~50% lower at any time point in perforated ceils (Fig. 
3).  Both intact and SL-O-perforated cells released within 
the first 5 min ~40% of the total Tf released in 65 min. In 
the case of perforated cells some variability (24-32 %) in the 
total amount of [~25I]Tf  released over 65 min was observed. 
Most of this variability depended upon variability occurring 
during the first 5 min, when the rate of release is the fastest, 
while the fraction of release occurring between 5 and 65 min 
was always remarkably constant. The release of internalized 
"IT from SL-O-perforated cells  was  confirmed by immu- 
nofluorescence experiments. A significant fraction of Tf im- 
munoreactivity visible at the end  of a  1-h internalization 
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O-perforated  CHO  cells  as  demon- 
strated by immunofluorescence.  Perfo- 
rated cells were incubated for 65 min in 
the presence of 2 mM ATP before fixa- 
tion.  (A  and  B)  Double  labeling  for 
fl-tubulin and  for cellubrevin  (CB). A 
comparison with Fig.  1 C suggests that 
some, but not all, the microtubules have 
depolimerized.  (Cand D) Double label- 
ing  for  actin  (fluorescein-conjugated 
phalloidin)  and  for cellubrevin  (CB). 
Bar, 14 #m. 
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Figure 3.  Release of preinter- 
nalized  [~2SI]Tf from  intact 
and  SL-O-perforated  CHO 
cells. Intact cells (full squares) 
and SL-O perforated cells (in 
2  mM  ATP)  (open  circles) 
were incubated for 5, 20,  35, 
and  65  min  at  37°C. The 
amount of [~25I]Tf  released in 
each  sample  is  expressed  as 
the  percentage  of  the  total 
[~25I]Tf  present in that sample 
(cell-associated  plus  released 
Tf). For each time point and 
treatment,  values  represents 
the mean + SD of  three deter- 
minations  from a representa- 
tive experiment.  The amount 
of p2~I]Tf present  in the  su- 
pernatant  of the cell  suspen- 
sion at 0 min was substracted 
from the  amount  of  p~SI]Tf 
present in each sample super- 
natant. 
(Fig. 4 A) was lost after cell perforation and a 65-min incuba- 
tion in the presence of ATP (Fig. 4 C). Tf immunoreactivity 
was  generally drastically  decreased  from all  cell  regions, 
consistent with a good preservation of the cell cytoskeleton, 
and therefore, most likely, of mechanisms of vesicle translo- 
cation. 
We  next investigated  whether  p25I]Tf release  from SL- 
O-perforated CHO cell exhibits the properties expected for 
a release occurring by exocytosis. The release was found to 
be dependent on the presence of ATP,  because exposure of 
the perforated cells to an ATP-depleting system inhibited re- 
lease (Fig. 5). This inhibition was complete after a lag phase, 
possibly needed  to  achieve a  maximal  ATP depletion.  A 
similar lag phase in the effect of the ATP-depletion system 
on constitutive exocytosis of glycosaminoglycans from per- 
forated CHO cells was reported by Miller and Moore (1991). 
Release of p25I]Tf from perforated CHO cells was also de- 
pendent on temperature; when cells previously shifted for 5 
min to  37°C  to  allow  SL-O to  act were returned  to  ice, 
[~2~I]Tf release was completely blocked (Fig.  5).  Addition- 
ally, release was also completely inhibited by treatment with 
NEM,  as expected for a  release requiring  NSE  and there- 
Galli et al.  Cellubrevin and Exocytosis of Recycling Vesicles  1019 Figure 4. Release of preinternalized human Tf from SL-O-perforated CHO cells in the absence or presence of TeTx-LC. Cells were first 
incubated with human II (20/xg/ml) for 1 h then exposed to SL-O and incubated for 65 min with 2 mM ATP and in the absence or presence 
of 200 nM TeTx-LC before fixation. The figure shows three pairs of micrographs double labeled for human Tf (Tf) and for cellubrevin 
(CB) at the end of the internalization period (A and B), or at the end of the 65 min incubation without (C and D) or with toxin (E and 
F). Comparison of  A with C demonstrates the significant, but incomplete, release of Tf from perforated cells treated in control conditions. 
Residual cell-associated Tf immunoreactivity is more intense in toxin-treated cells (E) than in control cells (C). In toxin-treated cells (F) 
cellubrevin immunoreactivity has virtually  disappeared.  Bar,  14 t~m. 
fore, bona fide membrane fusion (S6Uner et al.,  1993a,b). 
These findings rule out the possibility that some of the re- 
lease of [t2~I]Tf from perforated cells may be due to a major 
cell lysis or to lysis of "If-containing vesicles independent 
from exocytosis. 
Effect of TeTx-mediated Cleavage  of  CeUubrevin on Tf 
Release  from Perforated Cells 
Cells in  suspension were perforated and incubated for 20 
min at 37°C in the presence of increasing concentrations (0, 
10, 30,  100, and 300 nM) of TeTx-LC. As illustrated in Fig. 
6, TeTx-LC treatment resulted in a dose-dependent inhibition 
of [~25I]Tf  release which correlated with a  dose-dependent 
cleavage of cellubrevin with a nearly maximal effect at 300 
nM. At this concentration no cellubrevin was left in the cell 
at the end of the 20-rain incubation. The half-maximal inhi- 
bition of [~25I]Tf  release occurred at •30  nM of TeTx-LC. 
Further experiments were then carried out with the maxi- 
mal concentration of the toxin (300 nM) to achieve a com- 
plete cleavage of cellubrevin in the first few minutes of incu- 
bation.  At  this  high  toxin  concentration,  cellubrevin  was 
completely degraded within 5 min (Fig. 7) and could not be 
detected even after overexposure of the autoradiogram (data 
not  shown).  SCAMPs  (Brand  and  Castle,  1993)  and  Tf 
receptor (McMahon et al., 1993), two other proteins present 
in the same vesicular carrier as cellubrevin, and tubulin, re- 
mained unaffected by this treatment even after 65 min (Fig. 
7),  demonstrating that the proteolytic activity of the toxin 
was specific for cellubrevin.  Furthermore,  no difference in 
the overall protein composition was observed between con- 
trol and toxin-treated cells in Coomassie blue-stained gels 
(data not shown). The time-course of [t2SI]Tf release in the 
presence or absence of 300 nM TeTx-LC is shown in Fig. 8 
A.  The inhibition of release produced by TeTx was already 
visible at 5 min and continued thereafter. At 65 min the inhi- 
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l~gure 5. Sensitivity of [l~I]Tf release to ATP depletion, tempera- 
ture and NEM. (Left)  [125I]Tf  release from SL-O-perforated cells 
at 37°C  in the presence  of 2 mM ATP (squares)  or of an ATP- 
depleting system consisting of 30 U/ml hexokinase and 3 mM gin- 
cose (open  circles).  (Center)  [l~I]Tf release  from SL-O-perfo- 
rated cells at 370C (squares) and 4°C (open circles) in the presence 
of 2 mM ATP. All cells were first incubated for 5 rain at 37°C after 
SL-O addition to allow pore formation. The 4°C samples were then 
transferred to an ice-water bath. (Right) Release from SL-O-perfo- 
rated cells at 37°C in the presence of 2 mM ATP. Cells were first 
incubated at 37°C for 2 min after SL-O addition to allow pore for- 
mation; they were subsequently incubated for 15 rain on ice with 
1 mM NEM plus 2 mM DTT (squares) or I mM NEM alone (open 
circles).  In the latter case,  NEM was quenched with 2 mM DTT 
for 5 min at the end of the 15-min incubation.  Cells were then al- 
lowed to release [~I]Tf at 370C for 5, 20, 35, and 65 min. Results 
are expressed as described  in Fig.  3. 
bition ranged from 20-33 % of the control release. Neverthe- 
less, in spite of the complete cleavage of cellubrevin, release 
of p25I]Tf still occurred although at a  lower rate. 
Immunofluorescence  staining  of perforated  cells  incu- 
bated  for  65  min  in  the  presence  of 200  nM  TeTx-LC 
confirmed these biochemical findings. Loss of the immuno- 
Figure  6.  Dose-dependent 
effect of TeTx-LC on p~I]Tf 
release and cellubrevin cleav- 
age in SL-O-perforated CHO 
cells. (Top) Release of [lzSI]Tf 
during a 20-min incubation in 
the  presence  of 2  mM  ATP 
and 0, 10, 30, 100, or 300 n_M 
Te'rx-LC.  Results  are  ex- 
pressed as described in Fig. 3. 
(Bottom) The pellets from the 
same cell suspensions used to 
measure [lZq]Tf release were 
subjected  to  SDS-PAGE and 
levels of  cellubrevin were dem- 
onstrated by Western blotting. 
Figure  7.  Specificity of the proteolytic  effect of TeTx-LC on cel- 
lubrevin.  SL-O-perforated cells were incubated with 2 mM ATP 
in the absence or presence of 300 nM TeTx-LC. Levels of Tf  recep- 
tor, tubulin, SCAMPs, and cellubrevin remaining in the cell at the 
end of 5-, 20-, 35-, and 65-rain incubations were demonstrated by 
Western blotting. 
reactivity for Tf  prehaternalized during a 1-h incubation (Fig. 
4 A) from TeTx-LC-treated cells was less prominent (Fig. 4 
E) than in perforated cells incubated without toxin (Fig. 4 
C).  Furthermore,  the  typical cellubrevin immunoreactive 
pattern  (Fig.  4,  B  and  D)  had  practically  disappeared  in 
TeTx-LC-treated ceils (Fig. 4  F). 
Control experiments were performed with a mutant TeTx- 
LC which harbors a point mutation at position 234 (E--'Q) 
and which does not have proteolytic activity (McMahon et 
al., 1993; Yamasaki et al., 1994a). This mutation is thought 
to abolish the coordination of a water molecule in one of the 
four positions of the tetrahedron around the catalytic zinc ion 
and thus disrupts protease activity (Yamasaki et al., 1994a). 
As  shown  in  Fig.  8  B,  the  mutant  toxin  referred  to  as 
[Q234]TeTx-LC, did not produce any cellubrevin cleavage. 
Accordingly,  the difference between the release of [~25I]Tf 
occurring in the presence of wild-type toxin or of the mutant 
toxin was similar to the difference observed between TeTx- 
LC-treated sample and control samples (Fig.  8 A). When 
measured in the same experiment, the release of [~:ff]Tf  ob- 
served in the presence of [Q234]TeTx-LC was not statisti- 
cally different from the release observed in control prepara- 
tions (Fig.  8  C). 
The TeTx-LC-insensitive release of [~q]Tf was ATP de- 
pendent.  Fig.  9  shows  that  in  the  same  experiment,  an 
ATP-depleting  system  produced  a  greater  inhibition  of 
[~zSI]Tf  release than 300 nM TeTx-LC. Furthermore, the in- 
hibitory effect of TeTx-LC on [~2~I]Tf  release was not addi- 
tive to that of the ATP-depleting system alone, demonstrat- 
ing that TeTx-LC inhibits a release which is ATP dependent 
and therefore,  most likely, an exocytotic release. 
The persistence of a fraction of an ATP-dependent [l~I]Tf 
release after complete cellubrevin cleavage raises the possi- 
bility that CHO cells may contain another v-SNARE of the 
synaptobrevin/VAMP family resistant to TeTx-LC. To test 
for this possibility, we analyzed CHO cells by Western blot- 
ting with anti-synaptobrevin antibodies (see Materials and 
Galli et al. Cellubrevin and Exoeytosis of Recycling Vesicles  1021 Methods) known to cross-react with the three mammalian 
synaptobrevin/VAMP homologues. None of  these antibodies 
detected a TeTx-LC-resistant  protein in the molecular weight 
range of synaptobrevins. These data suggest either that a cel- 
lubrevin isoform which is not detected by available antibodies 
is present in CHO cells or, alternatively, that the TeTx-LC- 
resistant release relies on a  synaptobrevin/VAMP-indepen- 
dent secretion mechanism. 
Figure  8.  Time-course of the action of TeTx-LC and comparison 
with  the  action  of the  mutant,  proteolytically  inactive,  toxin 
:[234Q]TeTx-LC. All incubations were performed in the presence 
of 2 mM ATP and in the absence or presence of 300 nM toxin as 
indicated. Results are expressed as described in Fig. 3. (A, Left) 
[l~I]Tf  release in the presence (open circles)  or absence (squares) 
of TeTx-LC.  The effect of the toxin is significant compared to con- 
trois at all time points with P < 0.01 using student's T-test. (Right) 
[nSI]Tf release  in  the  presence  of TeTx-LC (open  circles)  or 
[234Q]TeTx-LC (squares).  The  effect  of the toxin is  significant 
compared to the mutant at all time points with P < 0.01 using stu- 
dent's T-test. (B) Western-blot analysis of cellubrevin content in 
cell pellets corresponding to the samples used for the [~25I]Tf  re- 
lease assays shown in A.  Already at 5 rain cellubrevin has been 
completely cleaved. (C) [n5I]'I¥  released in 65 rain in the absence 
or presence of [234Q]TeTx-LC.  The difference between the amount 
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Figure 9. ATP dependence of 
the release of [12q]Tf  which is 
resistent to the action of  TeTx- 
LC  (300  nM).  SL-O-perfo- 
rated cells were incubated for 
65 min with the additions in- 
dicated in the figure. Results 
are expressed as the mean -I- 
SD of six values. Using the 
student's  T  test,  the  release 
observed in the presence of 2 
raM ATP alone was found to 
be statistically different from 
the other three conditions (P 
< 0.01). The effect of the toxin 
in the presence  of ATP was 
also significantly different (P 
< 0.01) from the effect of the 
ATP-depleting system alone. The effect of the toxin in the presence 
of the ATP depleting system was not significantly different when 
compared to the effect of the ATP-depleting system alone. 
Discussion 
Our findings provide evidence that cellubrevin plays a role 
in exocytosis and more generally that proteins of the synap- 
tobrevin/VAMP family participate in exocytosis of recycling 
vesicles in nonneuronal cells. Exocytosis of vesicles which 
recycle Tf receptor takes place constitutively and is not sub- 
ject to phasic regulation. Thus, these results support an im- 
portant and general role of proteins of the VAMP/synapto- 
brevin family both in constitutive and regulated exocytosis. 
Key tools which have made this study possible were two 
toxins: TeTx-LC and SL-O. TeTx is a  Zn  2+ protease which 
cleaves proteins of the synaptobrevin/VAMP family includ- 
ing  cellubrevin with  remarkable  specificity (Link et  al., 
1992;  Schiavo et al.,  1992a,b;  McMahon  et  al.,  1993). 
Since nonneuronal cells do not have a plasmalemma receptor 
for the tetanus holotoxin (heavy and light chain), they do not 
internalize the toxin and do not transloeate the light chain 
into the cytoplasm as is the case for neuronal cells. We have 
therefore used the toxin in combination with a cell perfora- 
tion procedure based on SL-O. 
SL-O is a pore-forming toxin which we have used here to 
selectively  perforate the plasmalemma (Ahnert-Hflger et al., 
1989a,  1993). The pores make possible the introduction of 
TeTx-LC and  other proteins  into  cells,  while  preserving 
sufficient cell integrity to allow the study of vesicular traffic 
over limited time scales (Miller and Moore,  1991,  1992). 
The well known property of apotransferrin to be released 
into the medium following exocytosis of the vesicles which 
recycle it to the cell surface, offered the possibility to moni- 
tor exocytosis of these vesicles by detecting release of prein- 
ternalized Tf (Podbilewicz and Mellman,  1990). Tempera- 
ture and ATP dependence, as well as NEM  sensitivity of 
[mI]Tf release supported the hypothesis that such release 
takes place by an exocytotic mechanism.  Furthermore its 
NEM sensitivity provides a first piece of  evidence suggesting 
that the underlying exocytotic  event is mediated by the fusion 
machine involving NSF (Wilson et al.,  1989) and SNAREs 
(S6llner et al.,  1993b). 
Purified recombinant TeTx-LC, which had been produced 
in bacteria, was applied to SL-O-perforated CHO cells. Its 
effect was extremely rapid and at high toxin concentrations, 
cellubrevin cleavage was complete by 5  min.  Cellubrevin 
cleavage correlated with a significant reduction of'If  release, 
which could be demonstrated both biocbemically and by im- 
munofluorescence. Since the toxin inhibits, rather than stim- 
ulates, release, one cannot attribute release to a nonspeeific 
action of the toxin leading to vesicle lysis. Specificity of the 
effect was further suggested by the lack of action of the mu- 
tant toxin ([Q234]TeTx-LC), which does not have any pro- 
teolytic activity (McMahon et al.,  1993).  The proteolytic 
effect  of  TeTx-LC  appeared to be extremely specific for cellu- 
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Schiavo et al.,  1992a,b). 
In spite of the clear impairment of [l~I]Tf release pro- 
duced by the toxin, 70% of [t2SI]Tf  release was independent 
of  cellubrevin and TeTx-LC insensitive. This finding suggests 
two alternatives. One is that one or more other proteins of 
the synaptobrevin/VAMP family (a v-SNARE), and not sen- 
sitive to TeTx-LC, coexist(s) with cellubrevin on recycling 
vesicles.  The other is that a  fusion mechanism based on 
v- and t-SNARE interactions may coexist with a v-SNARE- 
independent exocytotic mechanism. The former possibility 
is more attractive. First, the release assay is completely sen- 
sitive to NEM, a compound known to block NSF-SNARE- 
dependent fusion mechanisms. Second, at least two genes 
encoding synaptobrevin/cellubrevin homologues are present 
in yeast (Protopopov et al.,  1993) and disruption of one of 
the two genes is insufficient to produce a significant impair- 
ment of secretion. It is therefore likely that ceUubrevin may 
not be the only synaptobrevin homologue expressed in non- 
neuronal cells and that its function may be partially compen- 
sated by other synaptobrevin related proteins. These other 
proteins cannot be synaptobrevin I or II because antibodies 
which recognize these two isoforms failed to detect signifi- 
cant levels of such isoforms in CHO cells (our unpublished 
observations).  Furthermore, preliminary experiments with 
botulinum toxins D and F, which cleave proteins of the syn- 
aptobrevin family at sites that differ from the site cleaved by 
TeTx-LC (Schiavo et al., 1993b; Yamasaki et al., 1994a), did 
not produce a more severe inhibition of [~25I]Tf release than 
obtained with TeTx-LC. 
TeTx-LC  was  previously expressed  transiently in  CV-1 
cells resulting in virtually complete cleavage of cellubrevin 
(McMahon et al., 1993). The effect of this treatment on exo- 
cytosis was not investigated. Strikingly, however,  cells in 
which cellubrevin had been cleaved were still able to inter- 
nalize Tf by receptor-mediated endocytosis, indirectly sug- 
gesting that the Tf receptor is still brought to the cell surface 
by exocytosis. TeTx-LC was also expressed in the Sertoli 
ceils oftransgenic mice (Eisel et al., 1993). These mice were 
sterile,  consistent with  a  functional impairment of these 
cells. However, even in this case the presence of viable Ser- 
toli cells rules out an essential role of either cellubrevin or 
synaptobrevin I and II which are all sensitive to TeTx-LC 
cleavage in the mouse (Patarnello et al.,  1993). 
As indicated by its localization on Tf receptor-containing 
vesicles, cellubrevin must recycle between the cell surface 
and intracellular vesicles including endosomal intermedi- 
ates.  This  recycling is  similar to the recycling of synap- 
tobrevin I and II via synaptic vesicles (McPherson and De 
Camilli,  1994).  Potentially, cellubrevin may participate in 
fusion reactions in more than one step of the pathway. In a 
previous study Link et al. (1993) have used a cell-free endo- 
some fusion assay to determine whether ceUubrevin plays a 
role in endosome-endosome fusion. They found that com- 
plete cleavage of  cellubrevin by TeTx-LC did not produce any 
effect on the efficiency of endosome fusion. Notably, the en- 
dosome-endosome fusion is an homotypic fusion event (fu- 
sion between membranes of the same compartmen0, while 
exocytosis is a heterotypic fusion event (fusion between two 
different membranes).  Homotypic and heterotypic mem- 
brane fusion play distinct roles in the physiology of the cell 
and may be controlled by different mechanisms. Whether 
ceUubrevin is involved in the fusion of endocytotic vesicles 
with early endosomes remains to be elucidated. 
It also remains to be demonstrated whether cellubrevin is 
involved in pathways to the plasmalemma other than the 
receptor-mediated recycling pathway, such as, for example, 
the constitutive secretory pathway.  The distribution of en- 
dogenous cellubrevin in CHO cells (this study) and of over- 
expressed cellubrevin in CV-1 cells (McMahon et al., 1993) 
appear to be more widespread than the distribution of inter- 
nalized Tf.  Thus, the involvement of cellubrevin in other 
pathways can be anticipated. 
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